Ionalytics Corporation
Ottawa
About Ionalytics Corporation
Sensitivity, separation and detection are critical success factors in drug discovery. At Ionalytics, they have developed the Ionalytics SelectraTM, a front-end instrument that enhances the performance of mass spectrometers by providing dynamic ion filtering to: - improve efficacy of data - reduce drug development time Based on FAIMS (high-Field Asymmetric waveform Ion Mobility Spectrometry) technology, the Ionalytics Selectra filters and focuses ions within a highly tuned electrical field contained within an electrode set. The result is increased productivity of mass spectrometers in both qualitative and quantitative applications. The Ionalytics team is committed to providing innovative tools to help laboratory professionals determine a drug's potential for treating or curing illness. Comprised of seasoned business leaders, respected scientists and engineers with years of product development and support expertise, their collective talent and experience has resulted in a customer-oriented culture and a high performance instrument that helps bring new drugs to market quicker.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Website: ionalytics.com
- Phone: (613)842-0977
Canonical: https://fsome.com/organization/ionalytics-corporation-2086166 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.